EndoGastric Solutions in Seattle, WA.
http://www.ventureloop.com/ventureloop/vb_article.php?natId=528&p=1
EndoGastric Solutions (EGS) has announced that it has closed a round of Series E financing worth $21.5 million. The investment was led by Advanced Technology Ventures and included other current investors. EGS plans to use the funding to support its expanding commercial presence for its market-leading Natural Orifice Surgery (NOS) platform, a platform that includes the EsophyX and StomaphyX surgical devices.
2009 has been a transformational year for the company, seeing it more than double its revenue, case volume and commercial employee base. The company anticipates acceleration of its revenue growth in 2010. Over the past six months EGS has increased its sales and marketing organization to support 30 territories nationwide, and to include a complete marketing, training and reimbursement team. The financing is an indication of the support and enthusiasm shared by current investors for the products and procedures the company is developing.
EndoGastric Solutions is a pioneer in endoluminal procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and other GI disorders. EGS’ mission is to utilize the most current wisdom in gastroenterology and surgery to develop new transoral procedures and products to address the largest unmet needs in gastrointestinal diseases. EGS is headquartered in the Greater Seattle Area and was founded in 2002.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment